Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

This is a national single-blinded prospective multicenter randomized (1:1) controlled trial, with two parallel arms, using a PROBE methodology, including patients with complicated acute necrotizing pancreatitis who require DEN of WON collection after endoscopic drainage. We will compare 2 groups: conventional DEN and DEN with Endorotor®. The study will be offered to all consecutive patients fulfilling the eligibility criteria after endoscopic drainage for WON. Since the time between drainage and the first necrosectomy session is usually at least 48 hours a period of at least 24h will be allowed for the patient to consider options to participate or not. Information and collection of informed consent will be done by an investigating physician.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age≥18years

ASA<5

CT scan less than 7 days old

Hospitalized for acute necrotizing pancreatitis, whatever the cause, and who have undergone drainage of pancreatic collections for the following indications according to the revised Atlanta criteria (infection, organ compression, persistent organ failure)

Disqualifiers

No endoscopic drainage in place for the management of WON

Have already had a DEN session (endoscopic or else) before screening for inclusion

Life-expectancy < 1year (advanced cancer, etc)

Known haemostasis disorder (chronic thrombocytopenia, haemophilia, etc.)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Endorotor Group

    Device

    DEN will be performed with Endorotor 3.2 or ENDOROTOR PED® system depending on the position of cystoenterostomy. Endorotor 3.2 is slimmer and enters WON more easily when the transgastric access is located in the upper portion of the stomach). If needed: lavage, aspiration and conventional mechanical debridement could be used in addition during an ENDOROTOR-based DEN session.

  • Conventional group

    Other intervention

    DEN is performed conventionally with abundant lavage and mechanical debridement using a non-dedicated material (diathermic loop, polypectomy or Dormia basket) to catch pieces of necrosis

Treatment groups

64 Participants
are divided into 2 treatment groups
Group A: Endorotor GroupExperimental treatment 1 intervention
Group B: Conventional groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

evaluate the effectiveness of the Endorotor PED® device versus conventional technique for the endoscopic management of symptomatic walled-off necrosis during necrotizing acute pancreatitis.

The effectiveness of the operative approach (Endorotor 3.2/PED® or conventional technique) will be assessed by the period in days between the first DEN session and the confirmed complete necrosis resolution.

Time frame
5 month

Secondary outcomes

1

number of death

Time frame
10 month
2

number of new-onset multiple organ failure

Time frame
10 month
3

number of visceral perforation

Time frame
10 month
4

number of arterial perforation

Time frame
10 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.